SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000198
Filing Date
2021-10-12
Accepted
2021-10-12 08:00:36
Documents
16
Period of Report
2021-10-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20211012.htm   iXBRL 8-K 43545
2 EX-99.1 a20211012newhirespr_fina.htm EX-99.1 11547
6 GRAPHIC a20211012newhirespr_fina001.jpg GRAPHIC 271694
7 GRAPHIC a20211012newhirespr_fina002.jpg GRAPHIC 306004
8 GRAPHIC a20211012newhirespr_fina003.jpg GRAPHIC 255166
  Complete submission text file 0001485003-21-000198.txt   1350421

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20211012.xsd EX-101.SCH 1914
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20211012_lab.xml EX-101.LAB 24993
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20211012_pre.xml EX-101.PRE 13190
9 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20211012_htm.xml XML 11816
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 211316940
SIC: 2834 Pharmaceutical Preparations